Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda
BioPharma Dive,
Merck
Trends in immunotherapy use and survival impact in stage IV non-small cell lung cancer.
Overview of attention for article published in Journal of Clinical Oncology, May 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (74th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)
Readers on
- mendeley
- 1 Mendeley